Palo Alto Investors LP Clovis Oncology, Inc. Transaction History

Palo Alto Investors LP

$727 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $680,881 - $1.5 Million	476,141 Added 11.91%	4,473,967 $9.04 Million
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $1.31 Million - $2.32 Million	-486,585 Reduced 10.85%	3,997,826 $10.8 Million
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $72,150 - $155,100	15,000 Added 0.34%	4,484,411 $31.5 Million
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $520,560 - $833,760	108,000 Added 2.48%	4,469,411 $26.1 Million
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $1.56 Million - $2.66 Million	-274,378 Reduced 5.92%	4,361,411 $29.4 Million
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $1.59 Million - $4.63 Million	-420,497 Reduced 8.32%	4,635,789 $29.5 Million
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $1.01 Million - $5.51 Million	335,542 Added 7.11%	5,056,286 $52.7 Million
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $1.65 Million - $6.46 Million	-420,560 Reduced 8.18%	4,720,744 $18.6 Million
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $1.26 Million - $2.52 Million	-98,000 Reduced 1.87%	5,141,304 $76.5 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $212,573 - $597,142	18,278 Added 0.35%	5,239,304 $94.1 Million
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $7.25 Million - $12.2 Million	247,019 Added 4.97%	5,221,026 $153 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $42.8 Million - $63.5 Million	1,018,347 Added 25.74%	4,974,007 $226 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $27.7 Million - $37.4 Million	552,879 Added 16.25%	3,955,660 $209 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $4.22 Million - $6.19 Million	73,200 Added 2.2%	3,402,781 $231 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $224 Million - $282 Million	3,329,581	3,329,581 $274 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account